AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to Severe Atopic Dermatitis Biotech Investing
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
BLU INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc. Biotech Investing
BLU LOSS ALERT: ROSEN A TOP RANKED INVESTOR RIGHTS LAW FIRM, Encourages BELLUS Health Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Review Oncology Business on April 9, 2021 Pharmaceutical Investing
BLU SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc. Biotech Investing
BLU Investor Notice: Rosen, A Respected and Leading Firm, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
